Delivery Order SPE2DB22D3501-SPE2DB25FVD65

Award Date 4/3/25
Potential Completion Date 4/24/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,129.80 firm fixed-price delivery order is for Pfizer COVID-19 vaccine doses to be delivered between 2024-2025, under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical through November 2026. This IDC serves as a primary vehicle for...
This federal contract award, valued at $1,100.15, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Pfizer COVID-19 vaccines from 2024 to 2025. The contract is a Firm Fixed Price Delivery Order with a completion date of May 21, 2025. This award is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at $999,999,999.00, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,100.15 Firm Fixed Price delivery order is for the supply of Pfizer COVID-19 vaccines and related medical products from 2024 to 2025, with a potential performance period of up to 4 years. The contract is not set aside and was openly competed. Amerisourcebergen Drug Corp holds a significant $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,092.06 firm fixed price contract is for the delivery of Pfizer COVID-19 vaccine doses from 2024 to 2025, with a period of performance ending on November 29, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This federal contract award, issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, is for the delivery of Pfizer COVID-19 vaccines in the 2024-2025 timeframe. The $1,129.80 firm fixed-price delivery order has an ultimate completion date of January 13, 2025 and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is delivering these COVID-19 vaccines to support military healthcare programs globally through the company's existing...
This federal contract award is a delivery order worth $1,642.75 issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The award is for the provision of Pfizer COVID-19 vaccines between 2024-2025, with an ultimate completion date of November 7, 2024. The contract is a firm fixed-price arrangement with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order, valued at $1,135.77, is for the procurement of Pfizer COVID-19 vaccines with a 0.9mL dosage for the 2024-2025 period, under a Firm Fixed Price contract. The award has an ultimate completion date of November 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,622.03 delivery order is for the procurement of Pfizer COVID-19 vaccines for the 2024-2025 time period, including 0.9 mL dosages under an Emergency Use Authorization (EUA). The contract has an ultimate completion date of March 14, 2025 and is a Firm Fixed Price delivery order. There was no set-aside designation...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,271.56 firm fixed-price delivery order is for the supply of 0.9 mL Pfizer COVID-19 vaccines for the 2024-2025 timeframe, under an Expanded Use Authorization (EUA). The contract has an ultimate completion date of November 15, 2024 and was awarded on October 24, 2024. Amerisourcebergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,129.80, is for the procurement of Pfizer COVID-19 vaccine doses to support vaccine requirements from 2024 to 2025, with a potential treatment window of 6 months to 4 years. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB25FVD65
    Delivery Order

This federal contract award is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,100.15, is for the procurement of Pfizer COVID-19 vaccine doses for the 2024-2025 time period, with an ultimate completion date of April 24, 2025. The contract is a firm-fixed-price arrangement and does not have a set-aside designation.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular delivery order falls under the scope of that larger IDC contract.

Generated 7/3/25, 3:07 PM